BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Other Non Operating Income (2022 - 2025)

BullFrog AI Holdings' (BFRG) quarterly Other Non Operating Income came in at $19108.0 in Q4 2025, down 65.89% on a YoY basis from $56026.0 in Q4 2024, and down 2.58% quarter-over-quarter from $19614.0 in Q3 2025.

Analysis

BullFrog AI Holdings (BFRG) Other Non Operating Income (2022 - 2025) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Other Non Operating Income for 4 consecutive years, with $19108.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 65.89% year-over-year to $19108.0; the trailing twelve-month figure through Jun 2026 stood at $38722.0 (down 75.42% YoY), and the FY2025 full-year result was $102197.0, down 60.83% from the prior year.
  • Other Non Operating Income declined to $19108.0 in Q4 2025 per BFRG's latest filing, from $19614.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $78216.0 in Q2 2024 and bottomed at -$92959.0 in Q1 2023.
  • Historically, Other Non Operating Income has averaged $27504.2 across 4 years, with a median of $40082.0 in 2025.
  • The widest YoY moves for Other Non Operating Income: up 2051300.0% in 2023, down 24498.69% in 2023.
  • Over 4 years, Other Non Operating Income stood at $2.0 in 2022, then jumped by 2051300.0% to $41028.0 in 2023, then soared by 36.56% to $56026.0 in 2024, then plunged by 65.89% to $19108.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $19108.0, $19614.0, and $40082.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 19,108.00
Sep 30, 2025 19,614.00
Mar 31, 2025 40,082.00
Dec 31, 2024 56,026.00
Sep 30, 2024 61,455.00
Jun 30, 2024 78,216.00
Mar 31, 2024 65,197.00
Dec 31, 2023 41,028.00
Sep 30, 2023 56,924.00
Jun 30, 2023 67,413.00
Mar 31, 2023 -92,959.00
Dec 31, 2022 2.00
Sep 30, 2022 18.00
Jun 30, 2022 58.00
Mar 31, 2022 381.00